Article Information
History
- February 1, 2021.
Article Versions
- You are currently viewing Version 1 of this article (February 1, 2021 - 12:48).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Martí Colom-Cadena, PhD1,
- Jane Tulloch, BSc1,
- Rosemary J Jackson, PhD1,2,
- James H Catterson, PhD1,
- Jamie Rose1,
- Caitlin Davies, BSc1,
- Monique Hooley, Msc1,
- Alejandro Anton-Fernandez, PhD1,
- Sophie Dunnett, BSc1,
- Robert Tempelaar, MSc1,
- Makis Tzioras, MSc1,
- Nicholas J Izzo, PhD3,
- Susan M. Catalano, PhD3,
- Colin Smith, MD, RCPath4 and
- Tara L. Spires-Jones, DPhil*,1
- 1The University of Edinburgh Centre for Discovery Brain Sciences and UK Dementia Research Institute, Edinburgh
- 2Current address: MassGeneral Institute for Neurodegenerative Diseases, Massachusetts General Hospital, Harvard Medical School, USA
- 3Cognition Therapeutics Inc., Pittsburgh, PA, USA
- 4Centre for Clinical Brain Sciences and Sudden Death Brain Bank, University of Edinburgh, Edinburgh
- ↵*Correspondence to, Prof Tara Spires-Jones, Tara.spires-jones{at}ed.ac.uk, Centre for Discovery Brain Sciences, The University of Edinburgh, 1 George Square, Edinburgh EH8 9JZ, UK